![IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker? - ScienceDirect IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000649712062287X-fx1ab.jpg)
IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker? - ScienceDirect
![Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia - The Journal of Molecular Diagnostics Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia - The Journal of Molecular Diagnostics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6e3fdea2-2994-4f75-bcab-0b4ce0d871b6/gr1_lrg.jpg)
Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia - The Journal of Molecular Diagnostics
![Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia - The Journal of Molecular Diagnostics Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia - The Journal of Molecular Diagnostics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8946bed7-ebf4-4fb4-9c78-3ccf72a66ec5/gr2.jpg)
Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia - The Journal of Molecular Diagnostics
![Chronic Lymphocytic Leukemia: Prognostic Factors and Impact on Treatment - Terri L Parker - Discovery Medicine Chronic Lymphocytic Leukemia: Prognostic Factors and Impact on Treatment - Terri L Parker - Discovery Medicine](https://www.discoverymedicine.com/Terri-L-Parker/files/2011/02/discovery_medicine_matthew_p_strout_no_57_table_2.png)
Chronic Lymphocytic Leukemia: Prognostic Factors and Impact on Treatment - Terri L Parker - Discovery Medicine
![Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment | HTML Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment | HTML](https://www.mdpi.com/diagnostics/diagnostics-11-00853/article_deploy/html/images/diagnostics-11-00853-g001.png)
Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment | HTML
![Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia | Biomarker Research | Full Text Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia | Biomarker Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40364-020-00222-3/MediaObjects/40364_2020_222_Fig3_HTML.png)
Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia | Biomarker Research | Full Text
![JCM | Free Full-Text | Prognosis in Myelodysplastic Syndromes: The Clinical Challenge of Genomic Integration | HTML JCM | Free Full-Text | Prognosis in Myelodysplastic Syndromes: The Clinical Challenge of Genomic Integration | HTML](https://www.mdpi.com/jcm/jcm-10-02052/article_deploy/html/images/jcm-10-02052-g001.png)
JCM | Free Full-Text | Prognosis in Myelodysplastic Syndromes: The Clinical Challenge of Genomic Integration | HTML
![Frontiers | Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia | Oncology Frontiers | Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia | Oncology](https://www.frontiersin.org/files/Articles/484025/fonc-09-01496-HTML/image_m/fonc-09-01496-g001.jpg)
Frontiers | Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia | Oncology
![Frontiers | Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways | Genetics Frontiers | Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways | Genetics](https://www.frontiersin.org/files/Articles/627964/fgene-12-627964-HTML/image_m/fgene-12-627964-g001.jpg)
Frontiers | Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways | Genetics
Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia | Haematologica
![Cytogenetic and Molecular Predictors of Outcome in Acute Lymphocytic Leukemia: Recent Developments | SpringerLink Cytogenetic and Molecular Predictors of Outcome in Acute Lymphocytic Leukemia: Recent Developments | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11899-012-0122-5/MediaObjects/11899_2012_122_Fig1_HTML.gif)
Cytogenetic and Molecular Predictors of Outcome in Acute Lymphocytic Leukemia: Recent Developments | SpringerLink
![Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax - ScienceDirect Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120759276-fx1ab.jpg)